Henry Schein Announces Board and Executive Compensation Changes
Ticker: HSIC · Form: 8-K · Filed: Sep 9, 2025 · CIK: 1000228
| Field | Detail |
|---|---|
| Company | Henry Schein INC (HSIC) |
| Form Type | 8-K |
| Filed Date | Sep 9, 2025 |
| Risk Level | medium |
| Pages | 1 |
| Reading Time | 2 min |
| Sentiment | neutral |
Sentiment: neutral
Topics: governance, executive-compensation, board-changes
TL;DR
Schein's board shuffled, exec pay tweaked. Watch for governance shifts.
AI Summary
Henry Schein, Inc. announced on September 5, 2025, changes in its board of directors and executive compensation arrangements. The filing details the departure of certain officers and the election of new directors, alongside updates to compensatory plans for key executives.
Why It Matters
Changes in board composition and executive compensation can signal shifts in company strategy, governance, or financial outlook, impacting investor confidence.
Risk Assessment
Risk Level: medium — Changes in leadership and compensation can sometimes precede or accompany significant strategic shifts or financial performance changes, warranting investor attention.
Key Players & Entities
- Henry Schein, Inc. (company) — Registrant
- Delaware (jurisdiction) — State of incorporation
- 135 Duryea Road, Melville, New York 11747 (address) — Principal executive offices
FAQ
What specific roles have seen departures or appointments?
The filing indicates the departure of certain officers and the election of directors, but does not specify the exact roles affected in this summary.
When was the earliest event reported in this 8-K?
The earliest event reported is dated September 5, 2025.
What is Henry Schein, Inc.'s primary business?
Henry Schein, Inc. is in the wholesale of medical, dental, and hospital equipment and supplies (SIC code 5047).
What is the company's state of incorporation?
Henry Schein, Inc. is incorporated in Delaware.
What is the company's fiscal year end?
The company's fiscal year ends on December 27.
Filing Stats: 437 words · 2 min read · ~1 pages · Grade level 12 · Accepted 2025-09-09 16:05:20
Filing Documents
- d918815d8k.htm (8-K) — 22KB
- 0001193125-25-199164.txt ( ) — 129KB
- hsic-20250905.xsd (EX-101.SCH) — 3KB
- hsic-20250905_lab.xml (EX-101.LAB) — 17KB
- hsic-20250905_pre.xml (EX-101.PRE) — 11KB
- d918815d8k_htm.xml (XML) — 3KB
From the Filing
8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): September 5, 2025 Henry Schein, Inc. (Exact name of registrant as specified in its charter) Delaware 0-27078 11-3136595 (State or other jurisdiction of incorporation) (Commission File Number) (IRS Employer Identification No.) 135 Duryea Road , Melville , New York 11747 (Address of principal executive offices) (Zip Code) Registrant's telephone number, including area code: (631) 843-5500 (Former name or former address, if changed since last report.) Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions: Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Securities registered pursuant to Section 12(b) of the Act: Title of each class Trading Symbol(s) Name of each exchange on which registered Common Stock, par value $.01 per share HSIC The Nasdaq Global Select Market Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR 240.12b-2 of this chapter). Emerging growth company If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. Item5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. (b) As previously disclosed on April 1, 2025, James Breslawski transitioned from the role of President of Henry Schein, Inc. (the "Company") to Senior Advisor and member of the Company's Executive Management Committee ("current role"). On September 5, 2025, Mr. Breslawski transitioned out of his current role. In connection with his transition, Mr. Breslawski will receive payments and benefits under the Company's Executive Severance Plan. SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. HENRY SCHEIN, INC. (Registrant) Date: September 9, 2025 By: /s/ Kelly Murphy Kelly Murphy Senior Vice President and General Counsel